Joe Rogan’s back in the news as the Joe Rogan Experience topics collide with psychedelics policy shifts and media debates. He’s a US podcaster, UFC commentator, and comedian (born 1967).
North Carolina's Senate race is a key battleground with both parties nominating candidates. Cooper, a Democrat, faces Whatley, backed by Trump, in a contest that could influence control of the Senate. The race is highly expensive and closely watched, with primary results expected tonight.
Joe Rogan expressed concern over Donald Trump’s age and decision to escalate tensions with Iran, criticizing the lack of clear evidence and questioning the rationale behind the military strikes. Rogan, a prominent podcast host, highlighted fears of a potential World War III and disillusionment with Trump’s deviation from campaign promises.
Rep. Tim Burchett has revealed he was briefed on classified extraterrestrial issues and advocates for full disclosure. He warns that releasing what he has seen could cause public upheaval. The story also covers recent mysterious scientist disappearances and ongoing government transparency efforts on UFOs.
Recent articles highlight ongoing tensions within the Democratic Party over far-left figures like Hasan Piker. Critics argue that Piker's controversial views and associations threaten the party's image, while some Democrats defend his presence, reflecting a broader struggle over ideological boundaries and media influence.
The US government has implemented new policies to accelerate research and development of psychedelics, including psilocybin, MDMA, and ibogaine. The move involves FDA fast-tracking and funding for state-level studies, aiming to improve treatments for mental health and addiction. This follows recent political and scientific developments.
President Trump has acknowledged that his previous claims of reducing drug prices by over 100% are mathematically impossible. During a drug pricing event, he explained his use of different calculation methods and defended his efforts to lower medication costs through new deals with pharmaceutical companies, including Regeneron.
The number of missing or dead scientists has grown to at least 12, with FBI and congressional investigations underway. Experts caution against drawing connections amid online speculation, while lawmakers and officials review potential links and motives behind the cases.